Tu1052 A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of TAK-438 (10 mg or 20 mg Once-Daily) Compared to Lansoprazole (15 mg Once-Daily) in a 24-Week Maintenance Treatment for Healed Erosive Esophagitis
Umegaki, Eiji, Iwakiri, Katsuhiko, Hiramatsu, Naoki, Sakurai, Yuuichi, Hori, Tetsuharu, Kudou, Kentarou, Nishimura, Akira, Ashida, KiyoshiVolume:
146
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(14)62675-5
Date:
May, 2014
File:
PDF, 390 KB
english, 2014